Literature DB >> 15528723

Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan.

Hisaaki Nishio1, Masaru Komatsu, Naohiro Shibata, Kouichi Shimakawa, Noriyuki Sueyoshi, Toshiro Ura, Kaori Satoh, Masahiro Toyokawa, Tatsuya Nakamura, Yasunao Wada, Tamaki Orita, Tomomi Kofuku, Katsutoshi Yamasaki, Masako Sakamoto, Shohiro Kinoshita, Masanori Aihara, Yoshichika Arakawa.   

Abstract

A total of 19,753 strains of gram-negative rods collected during two 6-month periods (October 2000 to March 2001 and November 2001 to April 2002) from 13 clinical laboratories in the Kinki region of Japan were investigated for the production of metallo-beta-lactamases (MBLs). MBLs were detected in 96 (0.5%) of the 19,753 isolates by the broth microdilution method, the 2-mercaptopropionic acid inhibition test, and PCR and DNA sequencing analyses. MBL-positive isolates were detected in 9 of 13 laboratories, with the rate of detection ranging between 0 and 2.6% for each laboratory. Forty-four of 1,429 (3.1%) Serratia marcescens, 22 of 6,198 (0.4%) Pseudomonas aeruginosa, 21 of 1,108 (1.9%) Acinetobacter spp., 4 of 544 (0.7%) Citrobacter freundii, 3 of 127 (2.4%) Providencia rettgeri, 1 of 434 (0.2%) Morganella morganii, and 1 of 1,483 (0.1%) Enterobacter cloacae isolates were positive for MBLs. Of these 96 MBL-positive strains, 87 (90.6%), 7 (7.3%), and 2 (2.1%) isolates carried the genes for IMP-1-group MBLs, IMP-2-group MBLs, and VIM-2-group MBLs, respectively. The class 1 integrase gene, intI1, was detected in all MBL-positive strains, and the aac (6')-Ib gene was detected in 37 (38.5%) isolates. Strains with identical PCR fingerprint profiles in a random amplified polymorphic DNA pattern analysis were isolated successively from five separate hospitals, suggesting the nosocomial spread of the organism in each hospital. In conclusion, many species of MBL-positive gram-negative rods are distributed widely in different hospitals in the Kinki region of Japan. The present findings should be considered during the development of policies and strategies to prevent the emergence and further spread of MBL-producing bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528723      PMCID: PMC525181          DOI: 10.1128/JCM.42.11.5256-5263.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.

Authors:  H Bello; M Domínguez; G González; R Zemelman; S Mella; H K Young; S G Amyes
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

3.  Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.

Authors:  A Mavroidi; A Tsakris; E Tzelepi; S Pournaras; V Loukova; L S Tzouvelekis
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

4.  Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.

Authors:  M Campbell; E Mahenthiralingam; D P Speert
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain.

Authors:  Shizuko Iyobe; Haruko Kusadokoro; Ayako Takahashi; Sachie Yomoda; Toyoji Okubo; Akio Nakamura; Koji O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme.

Authors:  J J Yan; P R Hsueh; W C Ko; K T Luh; S H Tsai; H M Wu; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

7.  Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase.

Authors:  S Iyobe; H Kusadokoro; J Ozaki; N Matsumura; S Minami; S Haruta; T Sawai; K O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.

Authors:  G Cornaglia; A Mazzariol; L Lauretti; G M Rossolini; R Fontana
Journal:  Clin Infect Dis       Date:  2000-11-06       Impact factor: 9.079

9.  bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.

Authors:  Kyungwon Lee; Jong Back Lim; Jong Hwa Yum; Dongeun Yong; Yunsop Chong; June Myung Kim; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

10.  Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal.

Authors:  Olga Cardoso; Rui Leitão; Alexandra Figueiredo; João Carlos Sousa; Aida Duarte; Luísa Vieira Peixe
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

View more
  21 in total

1.  High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Authors:  Hisakazu Yano; Miho Ogawa; Shiro Endo; Risako Kakuta; Hajime Kanamori; Shinya Inomata; Noriomi Ishibashi; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Mitsuhiro Yamada; Koichi Tokuda; Hiroyuki Kunishima; Miho Kitagawa; Yoichi Hirakata; Mitsuo Kaku
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  Detection of IMP metallo-β-lactamase in carbapenem-nonsusceptible Enterobacteriaceae and non-glucose-fermenting Gram-negative rods by immunochromatography assay.

Authors:  Shigeyuki Notake; Mari Matsuda; Kiyoko Tamai; Hideji Yanagisawa; Keiichi Hiramatsu; Ken Kikuchi
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

5.  Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea.

Authors:  Dongeun Yong; Yeoung Seon Choi; Kyoung Ho Roh; Chang Ki Kim; Youn Hee Park; Jong Hwa Yum; Kyungwon Lee; Yunsop Chong
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Metallo-β-lactamase-producing Klebsiella pneumoniae infection in a non-hospital environment.

Authors:  Rumi Okazaki; Shuichi Hagiwara; Takao Kimura; Yutaka Tokue; Masahiko Kambe; Masato Murata; Makoto Aoki; Minoru Kaneko; Kiyohiro Oshima; Masami Murakami
Journal:  Acute Med Surg       Date:  2015-04-27

7.  Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Noriyuki Abe; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kaneyuki Kida; Kaori Satoh; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takumi Jikimoto; Shohiro Kinoshita; Kazuaki Miyamoto; Itaru Hirai; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

8.  Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.

Authors:  Koichi Tanimoto; Haruyoshi Tomita; Shuhei Fujimoto; Katsuko Okuzumi; Yasuyoshi Ike
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital.

Authors:  M Biendo; B Canarelli; D Thomas; F Rousseau; F Hamdad; C Adjide; G Laurans; F Eb
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.